Updates with stock offering price details

** U.S.-listed shares of Belgian medical device maker Nyxoah SA NYXH.O plunge 48.8% to $1.48 and hit record low on Fri as it raises equity amid leadership transition to a U.S.-based CEO

** Co focused on obstructive sleep apnea solutions sells ~55.2 mln shares at $1.72 for $95 mln gross proceeds

** Offering price represents 40.3% discount to stock's last sale on Thurs

** It intends to use net offering proceeds to expand commercialization activities for its Genio system in the U.S., finance R&D and advance commercialization of the system outside of the U.S., among other purposes

** Co said late Thurs its board launched formal search process to appoint a new U.S.-based CEO "who will lead Nyxoah from within a critical market for the Company’s future growth"

** BofA lead bookrunner, joined by Bank Degroof Petercam for equity offering

** Co had ~43.66 mln shares outstanding as of Mar 31, per the prospectus

** With the decline, NYXH shares down ~68% YTD